Download Citation
Article Source:
Partial Agonist, Telmisartan, Maintains PPARγ Serine 112 Phosphorylation, and Does Not Affect Osteoblast Differentiation and Bone Mass
Kolli V,
Stechschulte LA,
Dowling AR,
Rahman S,
Czernik PJ,
et al.
(2014)
Partial Agonist, Telmisartan, Maintains PPARγ Serine 112 Phosphorylation, and Does Not Affect Osteoblast Differentiation and Bone Mass.
PLOS ONE 9(5): e96323.
https://doi.org/10.1371/journal.pone.0096323